Bovenschen
Immunotherapy for Brain Cancer
Our research focuses on the effector immune response of cytotoxic (killer) cells in brain cancer. We aim to translate this knowledge into (cellular) immunotherapy and nanomedicines that mimic effector phase immunity to target cancer.
Theses
Date: June 28, 2022
Date: September 8, 2020
Date: September 23, 2014
Date: December 12, 2013
Date: June 5, 2012
